Heparin protects basic and acidic FGF from inactivation.

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83

A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72

The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol (1997) 3.52

Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol (1989) 3.48

Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84

N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem J (1993) 2.36

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J (2012) 2.21

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A (1992) 1.94

Three-dimensional structure of human basic fibroblast growth factor. Proc Natl Acad Sci U S A (1991) 1.94

Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1988) 1.87

The elusive functions of proteoglycans: in vivo veritas. J Cell Biol (2000) 1.84

Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A (2000) 1.82

Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Natl Acad Sci U S A (1991) 1.73

A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev (1998) 1.73

Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol (1988) 1.69

Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol (1988) 1.67

Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67

Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol (1995) 1.59

Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55

Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest (1992) 1.55

Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell (1994) 1.46

Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol (1990) 1.42

Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest (1997) 1.39

pp60c-src is a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line. J Cell Biol (1995) 1.37

Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci U S A (1990) 1.37

Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J Cell Biol (1992) 1.36

High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U S A (1993) 1.29

The extracellular regulation of growth factor action. Mol Biol Cell (1992) 1.25

Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release (2007) 1.21

Decreased level of PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. J Cell Biol (1993) 1.21

Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A (1994) 1.19

Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest (1992) 1.19

Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1. Protein Sci (2012) 1.13

Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci U S A (1989) 1.12

Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol (2001) 1.12

Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc Natl Acad Sci U S A (1991) 1.08

Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials (2006) 1.08

Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution. Protein Sci (1993) 1.08

Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol (2004) 1.07

Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken) (2010) 1.06

Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol (1989) 1.04

Effective approach for calculations of absolute stability of proteins using focused dielectric constants. Proteins (2009) 1.04

Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. Br J Pharmacol (2006) 1.04

Fibroblast growth factor receptor-1 signaling in pancreatic islet beta-cells is modulated by the extracellular matrix. Mol Endocrinol (2007) 1.03

Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride. Biophys J (1999) 1.03

In vitro models of angiogenesis. World J Surg (2007) 1.02

A Network Map of FGF-1/FGFR Signaling System. J Signal Transduct (2014) 1.02

FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation. Wound Repair Regen (2009) 0.99

A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nat Chem (2013) 0.99

Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest (1990) 0.98

Increased protein stability of FGF1 can compensate for its reduced affinity for heparin. J Biol Chem (2009) 0.97

Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation. J Clin Invest (1996) 0.95

Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95

Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomater (2013) 0.95

Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers (2010) 0.94

Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc Natl Acad Sci U S A (1991) 0.94

Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials (2010) 0.94

Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93

Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine. Prog Polym Sci (2014) 0.92

Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development. J Cell Biol (1990) 0.91

Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier. Int J Nanomedicine (2010) 0.91

The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration. Biomaterials (2012) 0.91

Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes. Biophys J (2013) 0.90

Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells. Biomacromolecules (2010) 0.90

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol (1999) 0.90

Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells. Biochem J (1997) 0.89

Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors. Peptides (2007) 0.88

Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem J (1999) 0.87

Transformation-associated cytokine 9E3/CEF4 is chemotactic for chicken peripheral blood mononuclear cells. J Virol (1993) 0.86

Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide. J Biomol NMR (1999) 0.86

Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds. J Burn Care Res (2012) 0.86

The Int-2/Fgf-3 oncogene product is secreted and associates with extracellular matrix: implications for cell transformation. Mol Cell Biol (1991) 0.85

Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. J Mater Sci Mater Med (2012) 0.84

Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products. Biochem J (1999) 0.84

Effect of heparin on pulmonary fibroblasts and vascular cells. Thorax (1992) 0.83

Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J (1994) 0.83

Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am J Pathol (1993) 0.83

Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity. Sensors (Basel) (2009) 0.83

A retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas. Mol Cell Biol (1993) 0.82

Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus. Glycoconj J (2012) 0.82

Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. J Mater Sci Mater Med (2009) 0.82

Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A. J Cell Biol (1989) 0.81

Advanced imaging of skeletal manifestations of systemic mastocytosis. Skeletal Radiol (2012) 0.81

Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase. Biochem J (1997) 0.80

In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release. Nanoscale Res Lett (2009) 0.79

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination. Acta Neuropathol Commun (2014) 0.79

Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation. J Pharm Sci (2009) 0.79

Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol (2012) 0.79

Analytical approaches to uptake and release of hydrogel-associated FGF-2. J Mater Sci Mater Med (2009) 0.78

Susceptibility towards intramolecular disulphide-bond formation affects conformational stability and folding of human basic fibroblast growth factor. Biochem J (1998) 0.78

Mechanisms of FGF gradient formation during embryogenesis. Semin Cell Dev Biol (2015) 0.77

Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. Inflammation (2012) 0.77

A bio-inspired hybrid nanosack for graft vascularization at the omentum. Acta Biomater (2016) 0.77

A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2). Biomacromolecules (2016) 0.76

Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis. Graefes Arch Clin Exp Ophthalmol (1997) 0.76

Novel experimental and clinical therapeutic uses of low-molecular-weight heparin/protamine microparticles. Pharmaceutics (2012) 0.76

The acidic domain and first immunoglobulin-like loop of fibroblast growth factor receptor 2 modulate downstream signaling through glycosaminoglycan modification. Mol Cell Biol (1999) 0.75

New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia. Front Cardiovasc Med (2017) 0.75

Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75

Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts. Biochem J (1991) 0.75

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem (1991) 7.22

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun (1992) 5.31

Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science (1986) 5.12

Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A (1985) 4.60

Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature (1974) 4.58

A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol (1999) 4.51

Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 4.41

Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem (1975) 4.25

Transient simulation of last deglaciation with a new mechanism for Bolling-Allerod warming. Science (2009) 4.20

Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74

Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells. In Vitro (1978) 3.57

Structural characterization and biological functions of fibroblast growth factor. Endocr Rev (1987) 3.40

Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J (1986) 3.35

Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem (1978) 3.27

Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (1987) 3.27

Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc Natl Acad Sci U S A (1993) 2.98

Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth. Cancer Res (1978) 2.86

Growth factors in mammalian cell culture. Annu Rev Biochem (1976) 2.83

Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci U S A (1980) 2.71

Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46

Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem (1992) 2.39

Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc Natl Acad Sci U S A (1996) 2.35

The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32

Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27

The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol Chem (1985) 2.27

Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors. Exp Eye Res (1977) 2.27

Fibroblast growth factor. Mol Cell Endocrinol (1986) 2.26

Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol (2000) 2.18

Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J (1989) 2.14

Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life. Mol Cell Biol (1994) 2.09

Estimation of the cortical functional connectivity with the multimodal integration of high-resolution EEG and fMRI data by directed transfer function. Neuroimage (2005) 2.06

The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J Cell Biol (1995) 2.06

Characterization of the receptors for vascular endothelial growth factor. J Biol Chem (1990) 2.06

The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res (1979) 2.06

Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol (1978) 2.06

Acute toxicity and n-octanol/water partition coefficients of substituted thiophenols: determination and QSAR analysis. Ecotoxicol Environ Saf (2011) 2.04

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology (1994) 2.04

Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J Biol Chem (1986) 2.01

Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell (1980) 1.94

Extracellular matrix and control of proliferation of vascular endothelial cells. J Clin Invest (1980) 1.93

Growth control in cultured mouse fibroblasts: induction of the pleiotypic and mitogenic responses by a purified growth factor. Proc Natl Acad Sci U S A (1974) 1.93

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun (1989) 1.91

Identification, localization, and role of fibronectin in cultured bovine endothelial cells. Proc Natl Acad Sci U S A (1978) 1.89

Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan. J Cell Biol (1982) 1.88

Procedures for immunochemical study of histamine release from leukocytes with small volume of blood. J Allergy (1970) 1.87

PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J Cell Biol (1997) 1.79

Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos. Hum Reprod (2012) 1.79

Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ (1986) 1.75

Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat (2005) 1.74

Sequences within the last intron function in RNA 3'-end formation in cultured cells. Mol Cell Biol (1993) 1.67

Closure mechanisms of laryngeal vestibule during swallow. Am J Physiol (1992) 1.67

Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells. J Cell Biol (1983) 1.66

Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries. J Cell Physiol (1986) 1.63

Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function. Proc Natl Acad Sci U S A (1997) 1.61

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61

Respective roles of laminin and fibronectin in adhesion of human carcinoma and sarcoma cells. Nature (1981) 1.59

Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin. Proc Natl Acad Sci U S A (1974) 1.58

Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol Biochem Parasitol (2001) 1.58

Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke (2001) 1.58

Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum (1994) 1.57

Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect Immun (1998) 1.57

Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry (2000) 1.55

A comparison of the binding of epidermal growth factor to cultured granulosa and luteal cells. J Biol Chem (1978) 1.53

Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor. Endocrinology (1977) 1.53

Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J Cell Biol (1976) 1.52

Open resource metagenomics: a model for sharing metagenomic libraries. Stand Genomic Sci (2011) 1.52

Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52

Do plasma and serum have different abilities to promote cell growth? Proc Natl Acad Sci U S A (1980) 1.49

Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med (1996) 1.49

Effects of fibroblast and epidermal growth factors on ovarian cell proliferation in vitro. I. Characterization of the response of granulosa cells to FGF and EGF. Endocrinology (1977) 1.48

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infect Immun (2001) 1.47

Integrated cell isolation and polymerase chain reaction analysis using silicon microfilter chambers. Anal Biochem (1998) 1.44

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology (2000) 1.44

A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A (2001) 1.42

Heat stroke: a clinical review of 27 cases. Singapore Med J (1989) 1.42

Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): partial chemical and biological characterization. J Cell Physiol (1985) 1.41

Complication of adenoid cystic carcinoma and sialolithiasis in the submandibular gland: report of a case and its etiological background. Int J Oral Maxillofac Surg (2010) 1.39

Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A (1987) 1.38

Observation of an antimatter hypernucleus. Science (2010) 1.38

Growth response to hormones by a new rat ovary cell line. Nat New Biol (1972) 1.38

Post-operative infection after minimally invasive versus open transforaminal lumbar interbody fusion (TLIF): literature review and cost analysis. Minim Invasive Neurosurg (2011) 1.37

Fibroblast growth factor can substitute for platelet factor to sustain the growth of Balb/3T3 cells in the presence of plasma. Biochem Biophys Res Commun (1975) 1.37

Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc Natl Acad Sci U S A (1978) 1.36

Chip PCR. I. Surface passivation of microfabricated silicon-glass chips for PCR. Nucleic Acids Res (1996) 1.36

Control of proliferation of bovine vascular endothelial cells. J Cell Physiol (1977) 1.36

Endoscopic placement of expandable metal stents for biliary strictures--a preliminary report on experience with 33 patients. Endoscopy (1989) 1.35

Are factors originating from serum, plasma, or cultured cells involved in the growth-promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells? J Cell Physiol (1983) 1.35

Molecular analysis of Saccharomyces cerevisiae chromosome I. On the number of genes and the identification of essential genes using temperature-sensitive-lethal mutations. J Mol Biol (1992) 1.34

Cognitive impairment and mortality in older community residents. Am J Public Health (1994) 1.34

The production and localization of laminin in cultured vascular and corneal endothelial cells. J Cell Physiol (1981) 1.33

Purification in high yield of brain fibroblast growth factor by preparative isoelectric focusing at pH 9.6. J Biol Chem (1982) 1.32

Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochem Biophys Res Commun (1985) 1.31

Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med (2011) 1.29